Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant
According to a report in Globes, Edwards Lifesciences (NYSE: EW)+ agreed to acquire the remaining stake in Vectorious Medical Technologies.
The report states that Edwards’ deal values Vectorious at $497 million. It executed the acquisition in two stages, the report said, acquiring 52% of the company at a similar valuation in 2023. Today, the report says Edwards has acquired the remaining 48% stake to absorb the company fully.
